Discovery and Potential Functions of LRRCC1 (G85444)

Target Name: LRRCC1

NCBI ID: G85444

LRRCC1

Discovery and Potential Functions of LRRCC1

LRRCC1 (VFL1) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the Virginia family of proteins, which are characterized by the presence of a unique nucleotide in their amino acid sequence. LRRCC1 is also known as VFL1, and it is a potential drug target or biomarker.

The discovery of LRRCC1

The study of LRRCC1 was first proposed by a team of researchers led by Dr. Xinran Li at the University of California, San Diego. In their study, the researchers used transcriptomics and other techniques to identify the gene that encodes LRRCC1 in the mouse brain. They found that the gene was expressed in the brain and other tissues, and that it was highly expressed in the mouse brain.

Subsequent studies have confirmed that LRRCC1 is a highly conserved protein that is expressed in a variety of tissues, including the brain, heart, lungs, and gastrointestinal tract. It is also known as VFL1, based on the presence of a unique nucleotide in its amino acid sequence.

The potential functions of LRRCC1

Based on its expression in various tissues and its conserved nature, researchers have suggested that LRRCC1 may be involved in a variety of physiological processes in the body. One potential function of LRRCC1 is in cell signaling, as it is known to be involved in the regulation of cell proliferation and differentiation.

Additionally, LRRCC1 has been shown to be involved in the regulation of the immune response, as it has been shown to be expressed in immune cells and involved in the regulation of immune cell function. It has also been suggested that LRRCC1 may be involved in the regulation of inflammation, as it has been shown to be expressed in sites of inflammation in various tissues.

The potential uses of LRRCC1 as a drug target or biomarker

The potential uses of LRRCC1 as a drug target or biomarker are vast and varied. One potential use is in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as LRRCC1 has been shown to be involved in the regulation of neurodegenerate protein synthesis. Additionally, LRRCC1 may be a useful biomarker for monitoring the effectiveness of neurodegenerative treatments, as it is known to be expressed in the brain and may be affected by the progression of neurodegenerative diseases.

Another potential use of LRRCC1 is in the treatment of respiratory diseases, as it has been shown to be involved in the regulation of cell signaling in the lungs. Additionally, LRRCC1 may be a useful biomarker for monitoring the effectiveness of respiratory treatments, as it is known to be expressed in the lungs and may be affected by the progression of respiratory diseases.

The potential uses of LRRCC1 as a drug target or biomarker are only beginning to be explored, and more research is needed to fully understand its functions and potential uses. However, based on its expression in various tissues and its potential involvement in cell signaling and immune regulation, LRRCC1 is a promising candidate for further study as a drug target or biomarker.

Protein Name: Leucine Rich Repeat And Coiled-coil Centrosomal Protein 1

Functions: Required for the organization of the mitotic spindle. Maintains the structural integrity of centrosomes during mitosis

The "LRRCC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRCC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets